Galapagos is a commercial-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
Watch our CEO explain the 10-year partnership with Gilead.
This is the Galapagos way of working.
We are conducting clinical trials in several inflammatory indications, fibrosis, kidney and metabolic diseases.